Strategic Design of Catalytic Lysine‐Targeting Reversible Covalent BCR‐ABL Inhibitors

Journal:
Angewandte Chemie International Edition
Published:
DOI:
10.1002/anie.202105383
Affiliations:
4
Authors:
17
Institutions Authors Share
Experimental Drug Development Centre (EDDC), A*STAR, Singapore
12.500000
12.500000
0.74
National University of Singapore (NUS), Singapore
2.500000
0.15
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC), China
2.000000
0.12